Skip to main content
. 2013 Dec;57(12):6028–6033. doi: 10.1128/AAC.00891-13

Table 4.

Comparison of the efficacies of tigecycline combinations vs monotherapies after 24 and 48 h of treatmenta

Isolate TIG vs TIG + COL
TIG vs TIG + GEN
TIG vs TIG + MER
TIG vs TIG + RIF
COL vs TIG+COL
GEN vs TIG + GEN
MER vs TIG + MER
RIF vs TIG + RIF
Δlog P valueb Δlog P value Δlog P value Δlog P value Δlog P value Δlog P value Δlog P value Δlog P value
24 h of treatment
    K 1/4089 0.27 0.534 1.98 0.048 1.48 0.038 2.83 0.002 0.63 0.036 1.79 0.004 1.35 <0.001 1.28 0.006
    K 2/4179 2.97 0.026 4.16 0.010 1.57 0.094 1.86 0.044 2.80 0.008 4.22 0.006 1.57 0.094 0.62 0.315
    K 3/3268 1.00 0.081 2.21 0.095 −1.13c 0.148 1.72 <0.001 3.87 0.013 3.21 0.001 1.14 0.001 1.98 0.001
    K4/3712 0.05 0.918 0.80 0.074 −1.37c 0.002 0.62 0.125 5.46 0.001 −0.93c 0.054 0.47 0.135 2.77 0.002
    K5/2458 0.83 0.307 1.88 0.027 0.58 0.364 2.19 0.011 3.28 0.008 3.83 0.001 2.23 0.009 2.14 0.001
    K6/3189 −0.74c 0.108 0.38 0.136 −0.61c 0.014 0.22 0.065 3.63 0.001 4.50 0.001 3.75 0.001 2.22 <0.001
    K7/2868 −0.24c 0.515 0.46 0.199 0.07 0.843 0.48 0.182 2.01 0.063 0.98 0.100 1.65 <0.001 0.44 0.502
    K8/3342 −0.51c 0.186 0.35 0.614 −0.28c 0.597 2.38 0.008 1.69 0.003 1.57 0.061 1.27 0.024 2.02 0.002
    E1/1098 0.52 0.090 0.17 0.559 0.56 0.390 0.18 0.398 3.25 0.005 2.80 <0.001 2.31 0.035 2.96 <0.001
    ATCC 25922 1.68 0.155 2.67 0.006 3.68 0.010 2.43 0.005 3.43 0.027 4.28 0.006 1.90 0.037 3.17 <0.001
48 h of treatment
    K 1/4089 −0.51c 0.561 2.17 0.134 −1.58c 0.230 2.55 0.008 1.02 0.322 6.65 0.001 −0.60c 0.062 2.17 0.033
    K2/4179 3.07 0.004 4.88 0.001 1.15 0.004 5.46 <0.001 2.16 0.040 3.90 0.001 0.90 0.031 3.76 0.001
    K 3/3268 −0.90c 0.429 −1.21c 0.848 −0.18c 0.349 0.80 0.016 1.60 0.282 1.84 0.074 9.91 0.015 2.89 0.008
    K4/3712 0.97 0.110 1.28 0.153 0.24 0.611 1.56 0.001 0.42 0.053 3.16 0.001 5.04 0.002 3.95 0.003
    K5/2458 0.22 0.787 1.10 0.155 0.03 0.964 0.52 0.435 4.23 0.009 4.87 0.001 4.45 0.001 2.29 0.008
    K6/3189 0.15 0.871 1.71 0.001 −1.25c 0.001 2.55 0.001 3.87 0.014 2.76 0.038 1.32 0.012 2.73 0.003
    K7/2868 −0.64c 0.342 1.67 0.031 −1.52c 0.003 3.88 <0.001 2.11 0.019 4.05 0.001 0.58 0.305 2.48 0.031
    K8/3342 0.90 0.076 2.19 0.002 1.21 0.083 0.36 0.541 1.20 0.024 2.55 0.002 1.58 0.054 3.22 0.005
    E1/1098 −3.72c 0.002 −0.29c 0.495 −0.43c 0.241 −0.28c 0.612 0.45 0.370 3.72 0.001 2.81 0.001 3.68 0.002
    ATCC 25922 1.62 0.134 2.33 0.007 2.28 0.018 2.06 0.038 4.58 0.006 4.88 0.007 2.38 0.002 3.20 0.007
a

K, K. pneumoniae; E, E. coli; TIG, tigecycline; COL, colistin; GEN, gentamicin; MER, meropenem; RIF, rifampin.

b

A P value of <0.05 indicates significance and is shown in bold.

c

Antagonistic combination.